Chinese Inhalable COVID-19 Booster Vaccine Safe And Effective
Sumaira FH Published May 24, 2022 | 03:53 PM
A clinical trial in China has shown that an inhalable COVID-19 booster vaccine is safe and effective in adults
BEIJING, (UrduPoint / Pakistan Point News - 24th May, 2022 ) :A clinical trial in China has shown that an inhalable COVID-19 booster vaccine is safe and effective in adults.
Scientists led by Chen Wei with the academy of Military Medical Sciences in China developed an aerosolized adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) administered via oral inhalation.
Chen's group and the researchers from the Jiangsu Provincial Center for Disease Control and Prevention conducted a randomized, open-label, controlled trial to evaluate the vaccine's safety and immunogenicity as a booster jab in 420 Chinese adults who had previously received two doses of inactivated vaccine.
Eligible participants were randomly assigned between Sept. 14 and 16 last year to receive either a low dose or a high dose inhalable vaccine, or the vaccine identical to their previous two intramuscular shots, as a control group, according to the study published recently in the journal Lancet Respiratory Medicine.
The results showed that the low dose group had a concentration of serum neutralizing antibodies of 744.4 and the high dose group 714.1 14 days after the booster dose, significantly higher than that in the control group of 78.5. The vaccine-induced neutralizing antibodies can bind to the coronavirus and prevent it from infecting cells.
Also, only 26 and 33 participants reported adverse reactions in the low dose group and the high dose group, respectively, within 14 days of the booster vaccination, significantly fewer than the 54 reported in the control group, according to the study. The researchers concluded that a heterologous booster immunization with an aerosolized Ad5-nCoV in previously vaccinated adults is safe and highly immunogenic.
Now, they are planning a multicenter, randomized, double-blind, parallel-controlled efficacy trial of the inhaled vaccine as a booster dose following a Primary series of immunization with Ad5-nCoV in Mexico.
Related Topics
Recent Stories
PITB HR Wing organizes Eid Milan celebration for children at PITB Day Care Cente ..
SONY x TECNO - is this for real?
PTI to stage nationwide protests against alleged electoral frauds
Senate continues discussion on Presidential address to Joint Sitting of Parliame ..
Masood Khan calls for Pak-US cooperation for regional peace
Interior Minister starts Margalla Trail Patrol for security
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 26 April 2024
Today Gold Rate in Pakistan 26 April 2024
ICC Womens T20 World Cup Qualifier, Match 2: Ireland Women open with Comfortable ..
Robinson, bowlers help New Zealand go 2-1 up against Pakistan
Shahzeb Chachar to hold khuli kachehri on April 26
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
More Stories From Health
-
Vaccines save at least 154 million lives in 50 years: WHO
2 days ago -
UHS to issue MBBS degrees within three months after final result
2 days ago -
Rawalpindi woman gives birth to six babies
7 days ago -
DC calls for intensive anti-polio drive in ICT
8 days ago -
World Hemophilia Day observed to underscore importance of providing comprehensive care
9 days ago -
Six in a family with heart on the 'right side'
9 days ago
-
Diabetic disease increasing rapidly : Dr. Noor Elahi Memon
9 days ago -
World Hemophilia Day observed
9 days ago -
ATC dismisses bail petition of doctor involved in illegal kidneys transplant
17 days ago -
Dr. Shehzad warns against deviation from WHO guidelines on anti-smoking
17 days ago -
Health activists express concerns over attempts to derail tobacco control
19 days ago -
UHS declares MBBS first prof, MS urology exam results
28 days ago